Therapeutic Solutions International, Inc., (PINK:TSOI) announced today the signing of an exclusive intellectual property license agreement with Gustave Roussy Transfert of Villejuif, France for an issued U.S. patent covering the clinically tested “Dexosome” cancer immunotherapy product.
btw ceo and cfo acquired about half the common OS in 2014 at .002 and .003 as can be seen in form 4s
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.